BioCentury
ARTICLE | Clinical News

Antisoma preclinical data

December 3, 2001 8:00 AM UTC

ASOM published in Radiation Research that treatment with DMXAA increased the anti-tumor effects of radiotherapy in mouse models of breast cancer and sarcomas. The product, which is in Phase I trials t...